USANA Health Sciences (NYSE:USNA) Announces Earnings Results

USANA Health Sciences (NYSE:USNA) released its earnings results on Tuesday. The company reported $0.54 earnings per share for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.11), RTT News reports. USANA Health Sciences had a return on equity of 11.13% and a net margin of 6.29%. The business had revenue of $212.87 million during the quarter, compared to analysts’ expectations of $218.64 million. During the same quarter in the previous year, the business earned $0.89 EPS. USANA Health Sciences updated its FY 2024 guidance to 2.400-2.550 EPS.

USANA Health Sciences Trading Up 1.9 %

Shares of USANA Health Sciences stock traded up $0.78 during trading on Friday, hitting $42.62. 73,265 shares of the stock traded hands, compared to its average volume of 80,291. The firm has a market cap of $811.91 million, a P/E ratio of 13.24, a price-to-earnings-growth ratio of 1.50 and a beta of 0.90. USANA Health Sciences has a 52-week low of $40.51 and a 52-week high of $68.00. The stock’s fifty day simple moving average is $46.14 and its 200 day simple moving average is $47.03.

Insider Activity

In other news, insider Daniel A. Macuga sold 3,791 shares of the firm’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $47.14, for a total transaction of $178,707.74. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other USANA Health Sciences news, insider Daniel A. Macuga sold 3,791 shares of USANA Health Sciences stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $47.14, for a total value of $178,707.74. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO G Doug Iiekking sold 5,198 shares of USANA Health Sciences stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $44.76, for a total value of $232,662.48. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 31,591 shares of company stock worth $1,458,098. Company insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

USNA has been the topic of a number of recent analyst reports. DA Davidson reduced their target price on USANA Health Sciences from $46.00 to $38.00 and set a “neutral” rating on the stock in a research note on Thursday. StockNews.com lowered USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Wednesday.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.